| Comparison of HPLC methods in HbA1c determination | Murat AKŞİT, Giray BOZKAYA, Sibel BİLGİLİ, Nuriye UZUNCAN, Özlem UĞURLU DEMİREZEN, Alperen Halil İHTİYAR, Özge ESENLİK | 73–78 |
| Evaluation of Analytical Process in Clinical Laboratories: Six Sigma Methodology | Esin Avcı ÇİÇEK, Rukiye NAR, Bilal İLANBEY, Kenan GÜÇLÜ, Gamze TURNA, Dilek İREN EMEKLİ | 79–86 |
| Stability of Prothrombin Time and Activated Partial Thromboplastin Time in Frozen Plasma | İnanç KARAKOYUN, Fatma Demet İNCE | 87–93 |
| The Investigation of the Prevelance of MEFV Gene Mutations in Izmir | Murat AKSİT, Giray BOZKAYA, Murat ÖRMEN, Sibel BİLGİLİ | 94–99 |
| Comparison of Two Different Electrophoresis Systems in Transferrin Isoform Analysis | Öznur BİLEN, Zekiye Sultan ALTUN, Özlem GÜRSOY ÇALAN, Canan ÇOKER, Pınar AKAN | 100–111 |
| Association of Vitamin D with Blood Lipid Profile and HbA1c levels in Adults Who Admitted to Kayseri Training and Research Hospital | Mehmet Zahid ÇIRACI, Selma BULDU, Derya KOÇER, Çiğdem KARAKÜKCÜ | 112–117 |
| SCN1A, SCN2A, KCNQ2 Gene Mutations in Epilepsy With Generalized Tonic-Clonic Seizures | Burak BATIR, Ece ONUR, Berrin TUĞRUL, Hikmet YILMAZ, Zeynep AYTAÇ | 118–124 |
| Risk Perception in Health Services Sector: Hospital Laboratory Preliminary Study | Ramazan ŞEKEROĞLU, Erdem ÇOKLUK, Zübeyir HUYUT, Selin ÇOKLUK | 125–130 |
| Uncertainty of Measurement: Evaluation of Dehydroepiandrosterone Sulfate Analysis s | Sema Nur AYYILDIZ | 131–137 |
| Monitoring Anti-platelet Therapy with Platelet Function Testing | Burcu BARUTÇUOĞLU | 144–155 |